ANTERION
Heidelberg Engineering GmbH · Decision date Sep 11, 2026
What did the FDA decide?
The FDA's 510(k) database records K261019 for the device ANTERION, submitted by Heidelberg Engineering GmbH of Heidelberg, Germany, and received on 03/27/2026. The record lists the classification name Tomography, Optical Coherence, regulation number 886.1570, product code OBO, and the Ophthalmic medical specialty and review panel. The submission is a Traditional 510(k); the page states it was not reviewed by a third party, is not a combination product, and has no authorized Predetermined Change Control Plan.
On 09/11/2026 the FDA recorded a decision of Substantially Equivalent (SESE) for K261019. Under the 510(k) pathway this is a clearance finding, not a premarket approval of the device. The page lists clinical trials NCT04083742 and NCT04130490, but the source provides no summary statement, indications for use, or device description, so the specific components or changes reviewed and the basis for the equivalence finding remain unknown from this record.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Ophthalmic
- Decision date
- Sep 11, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261019
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Heidelberg Engineering GmbH
- Product code
- OBO
- Decision code
- SESE
- Decision date
- Sep 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Tomography, Optical Coherence.
- Applicant
- Heidelberg Engineering GmbH
- Product code
- OBO
- FDA device class
- 2
FDA decision timeline
K261019 received
Application receipt date recorded by FDA.
K261019 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Heidelberg Engineering GmbH
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Heidelberg
Sources and methodology
- Original FDA record: K261019
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records